Not finding it? Sign in to also search OpenAlex live.
-
Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)2021 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Volker J. Möbus, Hans‐Joachim Lück, Ekkehart Ladda, Peter Klare, Marcus Schmidt, Andreas Schneeweiß, +21 more
18citations -
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer2024 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Volker J. Möbus, Hans‐Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, +20 more
2citations -
SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT-ov78).
Benoît You, Nozomu Yanaihara, Gabriella Parma, Sylvie Chabaud, L. Del Carpio, Andrew R. Clamp, +10 more
2citations -
SALVOVAR: a pragmatic randomized phase III trial comparing the SALVage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic OVARian cancers2025 Therapeutic Advances in Medical Oncology article Medicine Ovarian cancer diagnosis and treatment Open access
Claire Chator, Nozomu Yanaihara, Sylvie Chabaud, Gabriella Maria Parma, Alexandra Lelia Dima, Andrew R. Clamp, +10 more
2citations -
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial2023 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Sonja B. Vliek, Florentine Hilbers, Erik D. van Werkhoven, Ingrid A.M. Mandjes, Rob Kessels, Sieta Kleiterp, +25 more
5citations -
Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)2026 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Mark Opdam, N. Ultee, Jill J.J. Geenen, Annelot G.J. van Rossum, Ingrid A.M. Mandjes, Sara Balduzzi, +5 more
0citations -
Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial2020 Journal of the American Heart Association article Medicine Chemotherapy-induced cardiotoxicity and mitigation Open access
Alexandra Maria Rüger, Andreas Schneeweiß, Sabine Seiler, Hans Tesch, Marion van Mackelenbergh, Frederik Marmé, +14 more
38citations -
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial2024 iScience article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Mark Opdam, Annelot G.J. van Rossum, Marlous Hoogstraat, Gergana Bounova, Hugo M. Horlings, Erik D. van Werkhoven, +39 more
4citations -
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer2021 BMC Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Christine Stürken, Volker J. Möbus, Karin Milde‐Langosch, Sabine Schmatloch, Peter Andreas Fasching, Josef Rüschoff, +13 more
6citations
11 results